Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Microarrays Changes Name to Decision Biomarkers

NEW YORK, Aug. 15 (GenomeWeb News) - Clinical Microarrays has changed its name to Decision Biomarkers, the company said today.


The company also said it has relocated to Waltham, Mass., from Natick, Mass.


According to Decision Biomarkers President and CEO Roger Dowd, the name change is a result of the company's efforts to "better communicate the scope and value of what [it] is preparing to deliver to the market."


The company is currently preparing to commercialize a fully-automated, multiplexed immunoassay system for quantitating protein biomarkers.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.